title: A study of electrical conductance of meridian in the obese during weight reduction.
abstract: This study was designed to investigate the electrical conductance of meridian in the obese during weight reduction. Ten obese including overweight (Body Mass Index, BMI > 26) and 30 healthy (non-overweight) people were recruited from Chung Yuan Christian University. The obese subjects were instructed to follow a weight reduction program that included diet control, exercise and oral intake of Prozac. A device, the design of which is based on the Ryodoraku theorem, was used to measure the electrical conductance of 12 meridians on both sides of the subjects. The results showed that: (1) the average coefficient of variation of the electrical conductances in 24 meridians of the obese group was statistically different from that of the healthy group (p < 0.05); (2) the average coefficient of variation of electrical conductance in the obese after weight reduction was significantly decreased than before the weight reduction program (p < 0.05); (3) the BMI and the electrical conductance of meridian was correlated in the obese (r = -0.77, p < 0.001) as well as in the healthy group (r = -0.92, p < 0.001). These findings suggest that electrical conductance of meridians can be a parameter to monitor weight, especially for obese people.
authors.affiliation: Department of Biomedical Engineering, Chung Yuan Christian University, Chungli, Taiwan. csw@mail.be.cycu.edu.tw
authors.forename: Ching-Sung
authors.initials: CS
authors.lastname: Weng
authors.forename: Yu-Li
authors.initials: YL
authors.lastname: Hung
authors.forename: Liang-Yu
authors.initials: LY
authors.lastname: Shyu
authors.forename: Yung-Hsien
authors.initials: YH
authors.lastname: Chang
mesh_terms: D000328:Adult; D015992:Body Mass Index; D016022:Case-Control Studies; D004038:Diet, Reducing; D017097:Electric Impedance; D015444:Exercise / Q000502:physiology; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D016740:Meridians; D009765:Obesity / Q000503:physiopathology* / Q000628:therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D015431:Weight Loss / Q000502:physiology*
chemical_list: D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors